Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
59 studies found for:    "Primary sclerosing cholangitis"
Show Display Options
Rank Status Study
21 Completed
Has Results
A Pilot Study of Vancomycin or Metronidazole in Patients With Primary Sclerosing Cholangitis
Condition: Primary Sclerosing Cholangitis
Interventions: Drug: Vancomycin;   Drug: Metronidazole
22 Completed
Has Results
Gastrointestinal Microbiota in Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin
Conditions: Primary Sclerosing Cholangitis;   Biliary Atresia
Intervention: Drug: Vancomycin
23 Recruiting A Pilot Study to Characterize Bile Acid Metabolism and Dysbiosis in Primary Sclerosing Cholangitis
Conditions: Primary Sclerosing Cholangitis;   Inflammatory Bowel Disease
Intervention: Drug: Vancomycin
24 Completed Norursodeoxycholic Acid in the Treatment of Primary Sclerosing Cholangitis
Condition: Primary Sclerosing Cholangitis
Interventions: Drug: norUDCA;   Drug: Placebo
25 Unknown  Short-term Stenting Versus Balloon Dilatation for Dominant Strictures in Primary Sclerosing Cholangitis
Condition: Primary Sclerosing Cholangitis
Interventions: Procedure: plastic endoprosthesis;   Procedure: balloon dilatation
26 Recruiting Phase 2 Study of NGM282 in Patients With Primary Sclerosing Cholangitis
Condition: Primary Sclerosing Cholangitis
Interventions: Biological: NGM282;   Other: Placebo
27 Active, not recruiting Obeticholic Acid (OCA) in Primary Sclerosing Cholangitis (PSC)
Condition: Primary Sclerosing Cholangitis (PSC)
Interventions: Drug: OCA;   Drug: Placebo
28 Completed Open Label Study to Evaluate Safety and Efficacy of LUM001 in Patients With Primary Sclerosing Cholangitis
Condition: Primary Sclerosing Cholangitis (PSC)
Intervention: Drug: LUM001
29 Recruiting Fecal Microbiota Transplantation for the Treatment of Primary Sclerosing Cholangitis.
Condition: Sclerosing Cholangitis
Intervention: Biological: Fecal Microbiota Transplantation
30 Recruiting Genomics of Primary Sclerosing Cholangitis (PSC)
Condition: Primary Sclerosing Cholangitis (PSC)
Intervention: Genetic: Genetic Analysis
31 Completed Evaluation of DHA for the Treatment of PSC
Conditions: Primary Sclerosing Cholangitis;   Colitis
Intervention: Drug: Docosahexaenoic Acid (DHA)
32 Completed A Pilot Study of Xifaxan to Treat Patients With PSC
Condition: Primary Sclerosing Cholangitis (PSC)
Intervention: Drug: Xifaxan
33 Recruiting Registry Trial to Determine pCLE Image Interpretation Criteria and Preliminary Accuracy for PSC Biliary Strictures
Condition: Primary Sclerosing Cholangitis
Intervention: Device: probe based confocal laser endomicroscopy
34 Unknown  NPD Measurements in PSC Patients
Condition: Primary Sclerosing Cholangitis
Intervention:
35 Completed Clinical Utility of the Spyglass System in Primary Sclerosing Cholangitis (PSC)
Condition: Sclerosing Cholangitis
Intervention:
36 Completed Trial of High-dose Urso in Primary Sclerosing Cholangitis
Condition: Sclerosing Cholangitis
Intervention: Drug: Ursodeoxycholic Acid
37 Completed Endomicroscopy in Primary Sclerosing Cholangitis Related Inflammatory Bowel Disease Surveillance
Conditions: Primary Sclerosing Cholangitis;   Inflammatory Bowel Disease
Intervention: Procedure: colonoscopy with endomicroscopy
38 Unknown  Telomere Length and Other Parameters of Telomere Dysfunction in PSC and Colitis
Conditions: Primary Sclerosing Cholangitis;   Inflammatory Bowel Disease
Intervention:
39 Terminated
Has Results
Fenofibrate for PSC
Condition: Primary Sclerosing Cholangitis
Intervention: Drug: fenofibrate
40 Terminated NPDT Evaluation in Children With CFTR and (PSC)
Conditions: Primary Sclerosing Cholangitis;   Inflammatory Bowel Disease
Intervention: Procedure: nasal potential difference testing

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-59) Show next page of results    Last Page
Indicates status has not been verified in more than two years